# Sharplink, Inc.: financial statements, quarterly

SBET · Nasdaq · CIK 1981535 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sbet.md) · [Financials](/companies/sbet/financials.md) · [Filings](/companies/sbet/filings.md) · [Insiders](/companies/sbet/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sbet/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.3](/filings/0001437749-24-035335.md) | [1.0 d](/filings/0001493152-24-012028.md) | [1.0](/filings/0001641172-25-010881.md) | [1.0](/filings/0001641172-25-024107.md) | [0.9](/filings/0001493152-25-021970.md) | [0.8 d](/filings/0001493152-26-009214.md) | [0.7](/filings/0001641172-25-010881.md) | [0.7](/filings/0001641172-25-024107.md) | [10.8](/filings/0001493152-25-021970.md) | [15.8 d](/filings/0001493152-26-009214.md) | [12.1](/filings/0001493152-26-021981.md) | [11.5](/filings/0001493152-26-036620.md) |
| Cost of revenue | $m | [1.0](/filings/0001437749-24-035335.md) | [0.7 d](/filings/0001437749-25-007821.md) | [0.7](/filings/0001641172-25-010881.md) | [0.7](/filings/0001641172-25-024107.md) | [0.7](/filings/0001437749-24-035335.md) | [0.7 d](/filings/0001437749-25-007821.md) | [0.6](/filings/0001641172-25-010881.md) | [0.5](/filings/0001641172-25-024107.md) | not reported | not reported | not reported | not reported |
| Gross profit | $m | [0.4](/filings/0001437749-24-035335.md) | [0.4 d](/filings/0001437749-25-007821.md) | [0.3](/filings/0001641172-25-010881.md) | [0.3](/filings/0001641172-25-024107.md) | [0.2](/filings/0001437749-24-035335.md) | [0.2 d](/filings/0001437749-25-007821.md) | [0.1](/filings/0001641172-25-010881.md) | [0.2](/filings/0001641172-25-024107.md) | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [1.8](/filings/0001437749-24-035335.md) | [2.0 d](/filings/0001437749-25-007821.md) | [2.0](/filings/0001641172-25-010881.md) | [1.5](/filings/0001641172-25-024107.md) | [1.0](/filings/0001493152-25-021970.md) | [1.2 d](/filings/0001493152-26-009214.md) | [1.1](/filings/0001493152-26-021981.md) | [2.4](/filings/0001493152-26-036620.md) | [12.0](/filings/0001493152-25-021970.md) | [27.0 d](/filings/0001493152-26-009214.md) | [9.9](/filings/0001493152-26-021981.md) | [9.1](/filings/0001493152-26-036620.md) |
| Operating income | $m | [(1.4)](/filings/0001437749-24-035335.md) | [(4.1) d](/filings/0001437749-25-007821.md) | [(1.7)](/filings/0001641172-25-010881.md) | [(1.2)](/filings/0001641172-25-024107.md) | [(0.8)](/filings/0001493152-25-021970.md) | [(1.1) d](/filings/0001493152-26-009214.md) | [(0.9)](/filings/0001493152-26-021981.md) | [(103)](/filings/0001493152-26-036620.md) | [105](/filings/0001493152-25-021970.md) | [(735) d](/filings/0001493152-26-009214.md) | [(685)](/filings/0001493152-26-021981.md) | [(393)](/filings/0001493152-26-036620.md) |
| Interest expense | $m | [0.3](/filings/0001437749-24-035335.md) | [0.4 d](/filings/0001493152-24-012028.md) | [0.3](/filings/0001493152-24-020437.md) | [0.0](/filings/0001641172-25-024107.md) | [0.0](/filings/0001437749-24-035335.md) | [0.0 d](/filings/0001493152-26-009214.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0001437749-24-035335.md) | [(0.0) d](/filings/0001437749-25-007821.md) | [0.0](/filings/0001641172-25-010881.md) | [0.0](/filings/0001641172-25-024107.md) | [0.0](/filings/0001493152-25-021970.md) | [(0.1) d](/filings/0001437749-25-007821.md) | [0.0](/filings/0001493152-26-021981.md) | [0.0](/filings/0001493152-26-036620.md) | [0.8](/filings/0001493152-25-021970.md) | [0.2 d](/filings/0001493152-26-009214.md) | [1.2](/filings/0001493152-26-021981.md) | [1.0](/filings/0001493152-26-036620.md) |
| Net income | $m | [(2.8)](/filings/0001437749-24-035335.md) | [(5.1) d](/filings/0001437749-25-007821.md) | [12.4](/filings/0001493152-25-021970.md) | [(0.5)](/filings/0001493152-25-021970.md) | [(0.9)](/filings/0001493152-25-021970.md) | [(0.9) d](/filings/0001493152-26-009214.md) | [(1.0)](/filings/0001493152-26-036620.md) | [(103)](/filings/0001493152-26-036620.md) | [104](/filings/0001493152-25-021970.md) | [(734) d](/filings/0001493152-26-009214.md) | [(686)](/filings/0001493152-26-036620.md) | [(394)](/filings/0001493152-26-036620.md) |
| Diluted EPS | $ per share | [(1.00)](/filings/0001437749-24-035335.md) | not reported | [40.31](/filings/0001641172-25-010881.md) | [(1.35)](/filings/0001641172-25-024107.md) | [(3.02)](/filings/0001493152-25-021970.md) | not reported | [(1.84)](/filings/0001493152-26-021981.md) | [(4.27)](/filings/0001493152-26-036620.md) | [0.62](/filings/0001493152-25-021970.md) | not reported | [(3.25)](/filings/0001493152-26-021981.md) | [(1.88)](/filings/0001493152-26-036620.md) |
| Basic EPS | $ per share | [(1.00)](/filings/0001437749-24-035335.md) | not reported | [47.48](/filings/0001641172-25-010881.md) | [(1.64)](/filings/0001641172-25-024107.md) | [(3.02)](/filings/0001493152-25-021970.md) | not reported | [(1.84)](/filings/0001493152-26-021981.md) | [(4.27)](/filings/0001493152-26-036620.md) | [0.70](/filings/0001493152-25-021970.md) | not reported | [(3.25)](/filings/0001493152-26-021981.md) | [(1.88)](/filings/0001493152-26-036620.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | period not labelled (2025-02-24) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.5](/filings/0001437749-25-007821.md) | [4.0](/filings/0001493152-24-020437.md) | [2.4](/filings/0001437749-24-026906.md) | [1.9](/filings/0001437749-24-035335.md) | [1.4](/filings/0001493152-26-009214.md) | [0.5](/filings/0001493152-26-021981.md) | [1.4](/filings/0001641172-25-010881.md) | [5.1](/filings/0001641172-25-024107.md) | [11.1](/filings/0001493152-25-021970.md) | [28.5](/filings/0001493152-26-036620.md) | [16.9](/filings/0001493152-26-021981.md) | [56.2](/filings/0001493152-26-036620.md) |
| Current assets | $m | [71.1](/filings/0001437749-25-007821.md) | [5.4](/filings/0001493152-24-020437.md) | [3.7](/filings/0001437749-24-026906.md) | [2.9](/filings/0001437749-24-035335.md) | [2.6](/filings/0001493152-26-009214.md) | not reported | [2.3](/filings/0001641172-25-010881.md) | [9.5](/filings/0001641172-25-024107.md) | [40.0](/filings/0001493152-25-021970.md) | [31.2](/filings/0001493152-26-036620.md) | [18.0](/filings/0001493152-26-021981.md) | [57.4](/filings/0001493152-26-036620.md) |
| Total assets | $m | [71.3](/filings/0001437749-25-007821.md) | [5.4](/filings/0001493152-24-020437.md) | [3.8](/filings/0001437749-24-026906.md) | [2.9](/filings/0001437749-24-035335.md) | [2.6](/filings/0001493152-26-009214.md) | not reported | [2.8](/filings/0001641172-25-010881.md) | [454](/filings/0001641172-25-024107.md) | [3,073](/filings/0001493152-25-021970.md) | [2,432](/filings/0001493152-26-036620.md) | [1,744](/filings/0001493152-26-021981.md) | [1,416](/filings/0001493152-26-036620.md) |
| Current liabilities | $m | [79.2](/filings/0001437749-25-007821.md) | [2.5](/filings/0001493152-24-020437.md) | [1.0](/filings/0001437749-24-026906.md) | [0.9](/filings/0001437749-24-035335.md) | [0.5](/filings/0001493152-26-009214.md) | not reported | [0.7](/filings/0001641172-25-010881.md) | [1.4](/filings/0001641172-25-024107.md) | [4.6](/filings/0001493152-25-021970.md) | [12.7](/filings/0001493152-26-036620.md) | [5.4](/filings/0001493152-26-021981.md) | [5.5](/filings/0001493152-26-036620.md) |
| Total liabilities | $m | [80.7](/filings/0001437749-25-007821.md) | [2.5](/filings/0001493152-24-020437.md) | [1.0](/filings/0001437749-24-026906.md) | [0.9](/filings/0001437749-24-035335.md) | [0.5](/filings/0001493152-26-009214.md) | not reported | [0.7](/filings/0001641172-25-010881.md) | [1.4](/filings/0001641172-25-024107.md) | [4.6](/filings/0001493152-25-021970.md) | [12.7](/filings/0001493152-26-036620.md) | [5.4](/filings/0001493152-26-021981.md) | [5.6](/filings/0001493152-26-036620.md) |
| Long-term debt | $m | [1.4](/filings/0001437749-25-007821.md) | not reported | [0.0](/filings/0001437749-24-026906.md) | [0.0](/filings/0001437749-24-035335.md) | [0.0](/filings/0001437749-25-007821.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [0.6](/filings/0001493152-24-012028.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(9.4)](/filings/0001493152-26-009214.md) | [2.9](/filings/0001493152-25-021970.md) | [2.8](/filings/0001493152-25-021970.md) | [2.0](/filings/0001493152-25-021970.md) | [2.1](/filings/0001493152-26-036620.md) | not reported | [2.1](/filings/0001493152-26-036620.md) | [453](/filings/0001493152-26-036620.md) | [3,068](/filings/0001493152-25-021970.md) | [2,419](/filings/0001493152-26-036620.md) | [1,739](/filings/0001493152-26-036620.md) | [1,411](/filings/0001493152-26-036620.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [18.3 d](/filings/0001437749-24-035335.md) | [(5.6) d](/filings/0001437749-25-007821.md) | [(19.3)](/filings/0001641172-25-010881.md) | [(1.7) d](/filings/0001641172-25-024107.md) | [(0.6) d](/filings/0001493152-25-021970.md) | [(1.3) d](/filings/0001493152-26-009214.md) | [(0.5)](/filings/0001493152-26-021981.md) | [(1.6) d](/filings/0001493152-26-036620.md) | [(6.3) d](/filings/0001493152-25-021970.md) | [(9.1) d](/filings/0001493152-26-009214.md) | [(10.6)](/filings/0001493152-26-021981.md) | [(7.2) d](/filings/0001493152-26-036620.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001437749-24-035335.md) | [0.0 d](/filings/0001437749-25-007821.md) | [0.0](/filings/0001641172-25-010881.md) | [0.0 d](/filings/0001641172-25-024107.md) | [0.0 d](/filings/0001493152-25-021970.md) | [0.0 d](/filings/0001493152-26-009214.md) | not reported | not reported | [0.0 d](/filings/0001493152-25-021970.md) | [0.0 d](/filings/0001493152-26-009214.md) | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [(0.0) d](/filings/0001493152-26-009214.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2023-03-31) | period not labelled (2023-06-30) | period not labelled (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [2.8](/filings/0001493152-24-020437.md) | [2.8](/filings/0001437749-24-026906.md) | [2.9](/filings/0001437749-24-035335.md) | [0.3](/filings/0001641172-25-010881.md) | [0.3](/filings/0001641172-25-024107.md) | [0.3](/filings/0001493152-25-021970.md) | [0.5](/filings/0001493152-26-021981.md) | [24.2](/filings/0001493152-26-036620.md) | [167](/filings/0001493152-25-021970.md) | [211](/filings/0001493152-26-021981.md) | [210](/filings/0001493152-26-036620.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 217,223,604 at 2026-08-03, from the cover of the [10-Q filed 2026-08-07](/filings/0001493152-26-036620.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.